AI checks cancer type during rectal surgery in real time
Part of Cancer, Digestive system clinical trials.
This study tests an AI system that helps identify cancer or polyp findings during rectal surgery or assessment, using real-time information. It may help surgeons classify tissue more accurately while you are already getting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed or suspected rectal polyp or tumour larger than 2 cm, or known rectal cancer, and you’re having surgery or an exam
- You are 18 years or older and can give informed consent
- You’re healthy enough (clinically fit) for the planned elective procedure
- You are not pregnant, breastfeeding, or planning pregnancy within 3 months (for people who can become pregnant)
- You do not have major kidney or liver problems
- You are not allergic to iodine-based contrast dye, and you can safely receive ICG (a special dye) based on listed medication and medical limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial-intelligence support tool that helps surgeons make decisions during surgery for rectal cancer. If you qualify, the tool may be used alongside the surgical team to support safer, more effective care.
This trial is testing a computer model that helps doctors predict how difficult rectal cancer surgery will be, so they can choose the best approach. The study aims to improve surgical planning and outcomes for patients.
This study is testing whether an artificial intelligence system can find very small amounts of leftover cancer (minimal residual disease) after treatment for rectal or esophageal cancer. If successful, this could help doctors detect a relapse earlier than current methods.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This trial tests a machine-learning (AI) system that may help guide surgeons during robotic rectal cancer operations. It’s meant to support safer, more accurate surgery while comparing outcomes to standard surgical guidance.
This trial uses artificial intelligence to help doctors better identify and classify polyps during a routine colonoscopy. It may lead to more accurate detection and fewer missed abnormalities.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.